Kuehn Law is investigating whether certain officers and directors of Zynex breached their fiduciary duties to shareholders. The investigation follows a federal securities lawsuit alleging that Zynex misled investors by shipping products in excess of need, inflating revenue, and filing false claims that drew scrutiny from insurers including Tricare. The lawsuit claims that positive statements about the company’s business, operations, and prospects were materially misleading. Shareholders who owned Zynex stock prior to March 13, 2023 are encouraged to contact the law firm.
Zynex IncInvestigation and lawsuit for alleged misleading revenue recognition and false claims to insurers.